Clinical Trial Update: Treatment of Chronic Active Antibody Mediated Rejection With Tocilizumab [NA]

View source ↗

Summary

The document reports that a clinical trial evaluating tocilizumab for chronic active antibody-mediated rejection in kidney transplant patients is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Active Antibody-mediated Rejection in Kidney Transplant
• Kidney Transplant Rejection

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Kidney Transplant Rejection | NA | Status: RECRUITING